SCHEMBL19976781

SCHEMBL19976781

CC(C)CN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2c(C(F)(F)F)cccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.35
MLYCD O95822 1/20 0.33
AURKA O14965 1/20 0.33
RPS6KB1 P23443 1/20 0.33
EGFR P00533 1/20 0.33
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HDAC4 P56524 1/20 0.32
MAPK1 P28482 5/20 0.31
DYRK1A Q13627 2/20 0.31
P2RX7 Q99572 1/20 0.31
EPHX2 P34913 1/20 0.31
HCRTR1 O43613 1/20 0.31
HCRTR2 O43614 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976857 0.90 MAPK1 (0.35) TRPA1AURKARPS6KB1KDM4EHTT
SCHEMBL19976804 0.86 TRPA1 (0.37) TRPA1AURKARPS6KB1EGFRDYRK1A
SCHEMBL19976782 0.85 MAPK1 (0.36) TRPA1EGFRKDM4EABL1BCR
SCHEMBL19976846 0.84 KDM4E (0.42) KDM4EABL1BCRMAPK1DYRK1A
SCHEMBL19976767 0.82 GSK3B (0.51) TRPA1LMNATP53MAPTMAPK1
SCHEMBL19976854 0.82 GSK3B (0.42) TRPA1LMNATP53MAPTMAPK1
SCHEMBL19976766 0.80 ABL1 (0.43) AURKARPS6KB1EGFRKDM4EHTT
SCHEMBL19976866 0.80 DYRK1A (0.42) AURKAMAPK1DYRK1A
SCHEMBL19976780 0.80 LMNA (0.33) KDM4EHTTNPSR1ABL1BCR
SCHEMBL19976776 0.79 GSK3B (0.48) TRPA1MAPK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed